RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 7 filers reported holding RECRO PHARMA INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,343,000 | -54.6% | 333,200 | -43.5% | 0.39% | -48.2% |
| Q1 2017 | $5,157,000 | +6.1% | 590,000 | -2.2% | 0.75% | +14.4% |
| Q4 2016 | $4,860,000 | -17.8% | 603,000 | -9.9% | 0.66% | +0.5% |
| Q3 2016 | $5,916,000 | -4.4% | 669,239 | -14.0% | 0.65% | -25.7% |
| Q2 2016 | $6,187,000 | +32.9% | 778,288 | -0.2% | 0.88% | +24.9% |
| Q1 2016 | $4,657,000 | -33.7% | 780,000 | 0.0% | 0.70% | -16.4% |
| Q4 2015 | $7,020,000 | -25.2% | 780,000 | 0.0% | 0.84% | -44.0% |
| Q3 2015 | $9,383,000 | -6.9% | 780,000 | 0.0% | 1.50% | +11.9% |
| Q2 2015 | $10,078,000 | +69.4% | 780,000 | +18.9% | 1.34% | +45.8% |
| Q1 2015 | $5,949,000 | +197.2% | 655,907 | -6.3% | 0.92% | +197.4% |
| Q4 2014 | $2,002,000 | -3.4% | 700,000 | 0.0% | 0.31% | -27.5% |
| Q3 2014 | $2,072,000 | -48.3% | 700,000 | +40.0% | 0.43% | -59.8% |
| Q2 2014 | $4,005,000 | +9.4% | 500,000 | 0.0% | 1.06% | +26.0% |
| Q1 2014 | $3,660,000 | – | 500,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |